| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.22 | 3e-05 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-05 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-05 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-05 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-05 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-05 |